Superworth

Agenus profit margin AGEN

Gross, operating and net profit as a share of revenue over the last twelve months, from 2012.

Net margin, 12 months
69.3%
Operating margin, 12 months
27.3%
Peer median
21.7%

Over the twelve months to Jun 30, 2026, Agenus kept 69.3% of its revenue as net profit, with an operating margin of 27.3% and a gross margin of 99.5%.

The median for 4 biotech stocks of a similar size is 21.7%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY20250.1%−17.7%99.1%
FY2024n/an/a99.5%
FY2023n/an/a98.0%
FY2022n/an/a89.2%
FY2021−8.1%8.7%98.8%
FY2020n/an/an/a
FY2019−70.3%−46.7%n/a
FY2018n/an/an/a
FY2017n/an/an/a
FY2016n/an/an/a
FY2015n/an/an/a
FY2014n/an/an/a
FY2013n/an/a82.4%
FY2012−71.0%−42.2%95.8%
FY2011n/an/a100.0%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY2669.3%n/a27.3%
Q1 FY2652.2%n/a6.6%
Q4 FY250.1%n/a−17.7%
Q3 FY25−32.9%n/a−56.6%
Q2 FY25n/an/a−86.0%
Q1 FY25n/an/an/a
Q4 FY24n/an/an/a
Q3 FY24n/an/a−61.6%
Q2 FY24n/an/a−71.2%
Q1 FY24n/an/a−85.5%
Q4 FY23n/an/an/a
Q3 FY23n/an/an/a

Against its peers

Companies in Biotechnology nearest Agenus' size, closest first, today.

CompanyProfit margin
AGENAgenus69.3%
PLXProtalix BioTherapeutics23.5%
MGTXMeiraGTx19.9%
VCELVericel7.9%
ADMAAdma Biologics33.0%
Peer median21.7%

Where Agenus ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Agenus

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.